JCSAI | Journal of Computer Science and Artificial Intelligence
← Back to Volume 6, Issue 3

Drug-Target Interaction Prediction Based on Deep Feature Fusion

Zhiyuan Xu
Vol. 6, No. 3, pp. 65-68, 2026 DOI: 10.54097/1ep5z649 March 29, 2026
Download PDF
Abstract.Drug-target interaction prediction plays an important role in drug discovery and drug repositioning. Traditional experimental screening methods are expensive and time-consuming, while existing computational approaches still have limitations in molecular representation and feature fusion. To address these problems, this paper proposes a drug-target interaction prediction model based on deep feature fusion. In the GCT-DTI, a Graph Isomorphism Network is used to capture the topological structure information of drug molecules, and Morgan fingerprints are introduced to supplement global chemical features. For target proteins, a Transformer encoder is employed to learn long-range dependency information from amino acid sequences. In addition, a cross-attention mechanism is designed to enhance the interaction between drug features and protein features. Experiments on the Human and C.elegans benchmark datasets demonstrate that the GCT-DTI achieves good performance in terms of AUC, Precision, and Recall. The results show that deep feature fusion can effectively improve the prediction accuracy of drug-target interactions and provide useful support for computer-aided drug discovery.
Keywords. Drug-target interaction deep learning feature fusion graph neural network Transformer
APA Citation Zhiyuan Xu (2026). Drug-Target Interaction Prediction Based on Deep Feature Fusion. Journal of Computer Science and Artificial Intelligence, 6(3), 65-68. https://doi.org/10.54097/1ep5z649

References

  1. Hughes J P, Rees S, Kalindjian S B, et al. Principles of early drug discovery. British Journal of Pharmacology, 2011, 162(6): 1239-1249.
  2. Berdigaliyev N, Aljofan M. An overview of drug discovery and development. Future Medicinal Chemistry, 2020, 12(10): 939-947.
  3. Öztürk H, Özgür A, Ozkirimli E. DeepDTA: deep drug-target binding affinity prediction. Bioinformatics, 2018, 34(17): i821-i829.
  4. Lee I, Keum J, Nam H. DeepConv-DTI: prediction of drug-target interactions via deep learning with convolution on protein sequences. PLoS Computational Biology, 2019, 15(6): e1007129.
  5. Zheng S, Li Y, Chen S, et al. Predicting drug-protein interaction using quasi-visual question answering system. Nature Machine Intelligence, 2020, 2(2): 134-140.
  6. Nguyen T, Le H, Quinn T P, et al. GraphDTA: predicting drug-target binding affinity with graph neural networks. Bioinformatics, 2021, 37(8): 1140-1147.
  7. Tsubaki M, Tomii K, Sese J. Compound-protein interaction prediction with end-to-end learning of neural networks for graphs and sequences. Bioinformatics, 2019, 35(2): 309-318.
  8. Wang X, Xia Z, Feng R, et al. SMFF-DTA: using a sequential multi-feature fusion method with multiple attention mechanisms to predict drug-target binding affinity. BMC Biology, 2025, 23(1): 120.
  9. Kipf T N, Welling M. Semi-supervised classification with graph convolutional networks. arXiv preprint arXiv:1609.02907, 2016.
  10. Vaswani A, Shazeer N, Parmar N, et al. Attention is all you need. Advances in Neural Information Processing Systems, 2017, 30: 5998-6008.
  11. Wang L, You Z H, Chen X, et al. A computational-based method for predicting drug-target interactions by using stacked autoencoder deep neural network. Journal of Computational Biology, 2018, 25(3): 361-373.
  12. Zhao W, Yu Y, Liu G, et al. MSI-DTI: predicting drug-target interaction based on multi-source information and multi-head self-attention. Briefings in Bioinformatics, 2024, 25(3): bbae238.